ASAH1 inhibition or downregulation leads to loss of cancer cell viability [173,174], anchorage-independent growth and metastatic potential [172], and sensitizes to cell death induced with Fas ligand [173] and radiotherapy [175]. This evidence concerns the gene ASAH1 and cancer.